InvestSMART

Proteomics International Laboratories Ltd (ASX:PIQ)

ALERT: Price-sensitive ASX Announcement for PIQ
Current share price for PIQ : $0.155 0 (0%)+
Announcement
Release
27 Jul 2026 9:48AM
Price at Release
$0.155
Full Release
download
Summary
Proteomics International Laboratories Ltd (ASX: PIQ) released its quarterly activities report and Appendix 4C cash flow statement for the quarter ending 30 June 2026. The company underwent a significant organizational restructure intended to transition to a commercially focused diagnostics company, resulting in cost savings and improved cash position. A national distribution agreement with Healius Limited was established, making them the exclusive distribution partner for the Promarker® portfolio in Australia. The company focused on commercialization of its PromarkerD technology and secured a patent for PromarkerEndo technology in the US, enhancing its intellectual property profile. The company reported net cash outflows from operations of $2.08 million, and had $3.5 million in cash and cash equivalents at the end of the quarter, which is estimated to cover 1.7 quarters of operations.
Key Points
  • Organizational restructure to focus on commercial diagnostics
  • National distribution agreement with Healius Limited for Promarker®
  • PromarkerD commercialization efforts and US health economics publication
  • US patent granted for PromarkerEndo technology
  • Cash outflows of $2.08 million for the quarter
  • Cash and cash equivalents of $3.5 million at quarter-end
  • Estimated 1.7 quarters of operational funding available
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.